Reneta plc. strategic management process

this slide shows how the reneta plc which is a renowned mnc in Bangladesh that produces medicines. It is shown that how they actually manages their strategy, how they implement their strategy and how they have acquired the market in bangladesh.

1. Strategic Management Process of Presented by: (Group-1)

2. Serial No. Name ID 1 Sabiha Tabassum B190203017 2 Md Sohel Hossain B190203033 3 Maisha Fahmida Ria B190203040 4 Md. Naeem Ul Fahim B190203061 5 Md. Abdul Aziz B190203064 6 Afia Fariha B190203065 7 Fahmidul Hasan B190203073 8 Farjana Akter Eti B190203075 9 Mahfuja Akter mili B190203077 10 Hafiza Akther B190203084 11 Afia Saiara B190203086 Group-1 Members

3. Fahim Always comes late in the class Not attentive and sleep in the class Mess up all his routine

4. Strategic Management It is a process that helps organizations achieve their goals and objectives by developing and implementing plans.

5. Pharmaceuticals Industry Insights 2 nd Largest potential source of foreign exchange revenues $6 billion Bangladesh's pharmaceutical industry is expected to be valued at over by 2025 30 pharmaceutical companies have started exporting their goods to foreign countries 5 th leading manufacturer in the industry 4.9% Market share captured in the pharmaceuticals industry. Field of Business Manufacturing, Marketing & Distribution of Human Pharmaceuticals , Animal Health Pharmaceuticals , Animal Health Medicines , Nutritional’s and Vaccines .

6. Business Model Bioequivalent products Cost management Competitive advantage and Superior profitability Of RENATA Business Model Strategies Distinctive Competencies Strategies Efficiency in operations Financial management (Increase revenue 14% in 2023-24) Distinctive Competencies Innovative Research Global presence Top-notch features Internal Analysis

7. S W O T strength Modern Technology Experienced Management Equipped with skilled & productive manpower Well inventory management system Weakness Lack of Marketing expertise Lack of accountability Subordinates are not included in the decision panel. . Opportunities Attend different trade fare to gather new ideas. Lead against weak competitors. Opportunity of developing in the market like US, UK and Canada. Choosing higher dynamic young people Threats Government tax and VAT structure Political Instability Lack of social securities Lack of governments policies for medical tourists.

8. PESTAL Analysis Political Factors Investment Hesitation Market Confidence Operational Challenges Economic Factors Positive Impact Negative Impact Social Factors Consumers are aware about Health CSR Workforce Dynamics

9. PESTAL Analysis (Cont.) Technological factors Therapeutic Development : use of AI Genomics & Biotechnology Remote monitoring and consultation availability of machineries Legal factors Rights to Intellectual Property DGDA Regulatory Compliance Rules Marketing Restrictions Environmental factors Ecological Methods: Eco-friendly production green chemistry techniques Adherence to Regulations

10. Porter’s 5 Factor Model Rivalry among existing companies (High) 265 Registered Running Companies 3 Big Domestic Company Like Square , Incepta and Beximco 80% of the branded drugs are Produced locally. Threat of Substitute product (High) 265 Substitute Companies have all the alternative products There remains big chance of consumer shifting their brand choices Threats of new entrants (Low) RENATA has a competitive advantage of brand loyalty of their consumers RENATA’s low cost products becomes a challenging for the new comers Bargaining power of buyer (Low) Consumers depends of physicians about medicine Price are strictly monitored by government Bargaining power of supplier (Moderately high) 90% of raw materials come form foreign suppliers Companies can easily switch their supplier

11. Strategic Process T he lengthy planning that a business does to function and accomplish its strategic objectives in the future Corporate level Strategy Business level Strategy Functional level Strategy

12. Corporate level strategy This strategy level is related to the decisions made by top-level management within an organization to establish its overall direction and scope Internal Growth Accountability For Environment and society Core values

13. Functional level strategy R & D Development Production strategies Marketing strategies Financing strategies HR strategies

14. Business level strategy Broad low cost strategy Focuses on minimizing production cost Allows the company to offer affordable, high-quality generic medicines. Successfully increased its market share among price-sensitive consumers by streamlining manufacturing processes and optimizing the supply chain Broad Differentiation Strategy Provides a diverse range of distinct, high-quality products The company recently expanded its bioequivalent product range from 50 to 63 New specialized products, including injectables and inhalers, have been introduced

15. Strategy Implementation Worldwide affiliates product development Specialization in pharmaceuticals and product line Global reach for specific items Regulatory approvals and product focus

16. Renata PLC is one of the leading and fastest growing pharmaceutical and animal health product companies in Bangladesh With the help of corporate, business, and functional level strategy, company is competing in the pharmaceuticals industry successfully Efficient employee and management make them always ready for adjusting their strategy With a clear plan, they can stand out from the competition with new ideas